Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Dysregulation of ErbB Receptor Trafficking and Signaling in Demyelinating Charcot-Marie-Tooth Disease.
Single-step grafting of aminooxy-peptides to hyaluronan: A simple approach to multifunctional therapeutics for experimental autoimmune encephalomyelitis.
Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis: A Systematic Review and Turkish Consensus Report.
Expanding the differential diagnosis of inherited neuropathies with non-uniform conduction: Andermann syndrome.
Expression of a Second Ecto-5'-Nucleotidase Variant Besides the Usual Protein in Symptomatic Phase of Experimental Autoimmune Encephalomyelitis.
Teriflunomide for the treatment of relapsing-remitting multiple sclerosis: patient preference and adherence.
Impact of Helicobacter pylori on multiple sclerosis-related clinically isolated syndrome.
Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes.
Cannabinoids and autoimmune diseases: A systematic review.
Microglia Plasticity During Health and Disease: An Immunological Perspective.
Effectiveness of multi-disciplinary rehabilitation for patients with Neuromyelitis Optica.
Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival.
Correction: Selective Blockade of CD28-Mediated T Cell Costimulation Protects Rhesus Monkeys against Acute Fatal Experimental Autoimmune Encephalomyelitis.
Optimal attenuation of experimental autoimmune encephalomyelitis by intravenous immunoglobulin requires an intact interleukin-11 receptor.
Plasma Exchange and Immunoadsorption in Pediatric Inflammatory Optic Neuropathy Resistant to Corticosteroid Therapy: Four French Cases.
Cardiac stunning as first manifestation of multiple sclerosis: A case report reminding us not to overlook cardiovascular autonomic dysfunction in multiple sclerosis.
Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapses.
Cost minimisation analysis of fingolimod vs natalizumab as a second line of treatment for relapsing-remitting multiple sclerosis.
Cytokines and soluble IL-4 in patients with acute optic neuritis and multiple sclerosis.
Therapeutic effect of anti-αv integrin mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Intramuscular IFNß-1a in multiple sclerosis: 'no proof of effectiveness' or 'proof of no effectiveness'?
Pharmaceutical approval update.
Mice with a deletion of the major central myelin protein exhibit hypersensitivity to noxious thermal stimuli: involvement of central sensitization.
A Cross-Sectional Examination of the Associations Between Symptoms, Community Integration, and Mental Health in Multiple Sclerosis.
Cost-Effectiveness of Escalating to Natalizumab or Switching Among Immunomodulators In Relapsing-Remitting Multiple Sclerosis In Italy.

Pages